Targeting activity of a TCR/IL-2 fusion protein against established tumors.
Wen J, Zhu X, Liu B, You L, Kong L, Lee HI, Han KP, Wong JL, Rhode PR, Wong HC.
Wen J, et al. Among authors: rhode pr.
Cancer Immunol Immunother. 2008 Dec;57(12):1781-94. doi: 10.1007/s00262-008-0504-7. Epub 2008 Mar 28.
Cancer Immunol Immunother. 2008.
PMID: 18369620
Free PMC article.